USP4 (N-term), 1-30 Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-USP4 (N-term), 1-30 antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityUSP4 (N-term), 1-30
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman
Isotypen/a
Formatpeptide affinity purified
Size0.08 mL, 0.4 mL
Concentrationvial concentration: 0.4
ApplicationsWestern Blot (WB), ELISA (EIA), Immunohistochemistry (IHC)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionThis USP4 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human USP4. Hydrolase that deubiquitinates target proteins such as the receptor ADORA2A and TRIM21. Deubiquitination of ADORA2A increases the amount of functional receptor at the cell surface. Plays a role in the regulation of quality control in the ER.
Immunogenn/a
Other Names[Ubiquitin carboxyl-terminal hydrolase 4; Deubiquitinating enzyme 4; Ubiquitin thioesterase 4; Ubiquitin-specific-processing protease 4; Ubiquitous nuclear protein homolog; USP4; UNP; UNPH]
Gene, Accession #[USP4], Gene ID: 7375, NCBI: NP_001238806.1, UniProt: Q13107
Catalog #MBS9204491
Price$165, $370
Order / More InfoUSP4 (N-term), 1-30 Antibody from MYBIOSOURCE INC.
Product Specific ReferencesMorgan, A.R., et al. Hum. Immunol. 71(6):602-609(2010) So, H.C., et al. Am. J. Med. Genet. B Neuropsychiatr. Genet. 153B (1), 103-113 (2010) : Zhao, B., et al. J. Cell. Mol. Med. 13 (8B), 1886-1895 (2009) : Milojevic, T., et al. Mol. Pharmacol. 69(4):1083-1094(2006) Wada, K., et al. Biochem. Biophys. Res. Commun. 342(1):253-258(2006)
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.